HOME >> BIOLOGY >> NEWS
Rare eye-movement disorder may shed light on brain and cardiovascular development

Researchers at Children's Hospital Boston, who specialize in studying the genetics of rare eye-movement disorders, have found a rare genetic syndrome whose implications go far beyond the eye, raising intriguing questions about human cardiovascular and brain development.

The syndrome involves a mutation to HOXA1, a gene that has been extensively studied in mice, but about which little is known in humans. HOXA1 belongs to a large family of HOX genes that govern very early embryonic development and the making of the body plan. HOXA1 is the first HOX gene turned on in mice, and presumably in the human body, and is involved in patterning of the growth of the head, face, and brainstem.

Mice that lack both copies of HOXA1 universally die. Until this study, no human HOXA1 mutation had ever been identified, and it was assumed that complete loss of HOXA1 function would be lethal. But the Children's investigators, led by graduate student Max Tischfield and neurologist Dr. Elizabeth Engle of the Children's Hospital Boston Program in Genomics and the Harvard Medical School Program in Neuroscience, have found living people with two mutated copies of HOXA1 -- from three different parts of the world.

"This is the first description of a human syndrome resulting from any of the HOX genes involved in brain development, and the first report of a total loss of any HOX gene in humans," says Engle, senior author of the study.

Tischfield and Engle had been studying genetic disorders that interfere with peoples' ability to move their eyes horizontally (left or right). Collaborators in Saudi Arabia alerted them to patients they'd been seeing who had not only restricted horizontal eye movement, but also deafness and motor impairments. The Saudi clinicians began to carefully reexamine their patients, while Tischfield and Engle looked at the patients' DNA to try to identify a causative gene.

All 9 patients with the syndrome (dubbed Bosley-Salih-Alorai
'"/>

Contact: Aaron Patnode
aaron.patnode@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
11-Sep-2005


Page: 1 2 3

Related biology news :

1. New strategy for treating allergic disorders
2. $9M grant awarded to University of Cincinnati for bipolar disorder research
3. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
4. New model for autism suggests women carry the disorder and explains age as a risk factor
5. A new method of adult stem cell growth efficacious in treatment of disorders of the cornea
6. Double identities lie behind chromosome disorders
7. Study finds regions of DNA that appear linked to autistic spectrum disorders
8. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
9. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
10. Scientists find new agent to fight genetic disorders -- Zorro-Locked Nucleic Acid
11. Gene controlling circadian rhythms may be involved in onset of bipolar disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/28/2020)... INDIANAPOLIS (PRWEB) , ... May 27, 2020 , ... ... of hc1 Workforce Advisor™ , a solution that uniquely combines lab testing ... to help employers systematically support the ongoing health and safety of employees returning ...
(Date:5/28/2020)... Texas (PRWEB) , ... May 28, 2020 , ... ... announced today that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT ... (ASCO) Annual Meeting which will take place virtually on May 29th, 2020. Dr. ...
(Date:5/25/2020)... ... 22, 2020 , ... Oxford Nanopore Technologies is in advanced development of a ... causes COVID-19. , The LamPORE assay is designed to be rapid, low ... large numbers of samples. Hardware and reagents sit outside current, squeezed supply chains ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 13, 2020 , ... ... Future Lab: Optimizing Workflows in the Life Science Lab . The comprehensive ... their lab, from water purification and liquid handling to contamination control. , The ...
(Date:5/5/2020)... ... May 05, 2020 , ... Smart Meter, ... of its iGlucose® LTE Cat-M Cellular Connected Diabetes Blood Glucose Monitor ... the industry’s newest and broadest cellular connectivity available, to provide patients with seamless ...
(Date:4/22/2020)... ... April 21, 2020 , ... Aniara Diagnostica is pleased to ... Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as ... quality and cost-efficient delivery. , For Research Use Only. Not for ...
(Date:4/1/2020)... , ... March 30, 2020 , ... ... its latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind ... solution that provides continual antimicrobial activity against microorganisms for up to 90 days. ...
Breaking Biology Technology:
Cached News: